Immupharma: blockbuster potential?Just recently I’ve taken a long position in Immupharma and am quite excited about the potential. One of the fellow members on a BB had posted a very well researched and balanced article that I would like to share. So, with courtesy of Sicilian_kan [cheers!]: ”(last updated on 26 April 2016: Disclaimer – no information […]
Hi DocG thank you for your great article! Appreciate it.I would like to add a little to it and apologize upfront for possibly being unclear, oversimplifying matters or sounding to harsh. If so that is not my intention. English is not my mother language a[...]
$ABIO Thanks Frank and you're welcome.[...]
$ABIO -long-fpHi Chip, thanks for keeping this great calendar up to date! The $ABIO catalyst (Ph 2b-3 interim efficiency data) seems to be a little late in the calendar. According to $ABIO data can be expected in august 2017http://arcabio.com[...]
$ABIO-long-fpHi Chip, thanks for keeping this great calendar up to date! The $ABIO catalyst (Ph 2b-3 interim efficiency data) seems to be a little late in the calendar. According to $ABIO data can be expected in august 2017http://arcabio.com/a[...]
Thank you doc! I appreciate you taking time to respond. Lack of knowledge, the mentioned WHO list, the 89.4% efficacy etcetera did make me believe Redhill was onto something and overlooked by the market. I trust your opinion and will act accordingly. Once[...]
$RDHL Long-FPRedHill Biopharma Announces Confirmatory Phase III Study Initiated with RHB-105 (TALICIA(TM)) for H. pylori InfectionSubject to a successful outcome and any additional regulatory feedback, the confirmatory Phase III study (ERADICATE H[...]
$LSE:IMM Long-FP.There's a company missing here that is conducting a pivotal phase 3 study concerning SLE. LSE (AIM) quoted Immupharma. All patients are recruited and top line results are expected Q1 2018.http://uk.advfn.com/stock-market/london/[...]
Or disappointment about another trial necessary because of statistical significance not high enough? Causing delays and further cash burn.[...]
$RDHL- long FP$RDHL Announced succesfull phase 3 top line results with BEKINDA for Acute Gastroenteritishttps://finance.yahoo.com/news/redhill-biopharma-announces-successful-phase-120000277.html (...) Top-line results indicated that the Phase II[...]
$AAVXF long 1/1. ABIVAX (Euronext Paris: FR0012333284 – members of the management team will participate at the 2017 RBC Capital Markets Global Healthcare Conference to be held on February 22-23 at the New York Palace in New York City.http://www.abiv[...]
Can't disagree with what you're saying. Possible scenarios. Cash burn could be lower. But I don't like them running on fumes and I feel they're doing just that. It's hard to predict the timing of an equity funding. I've been burned too many times by (deep[...]
$BIOC Per 9-30-16: current assets 1.8, current liabilities 5.0 (=-3.2). Equity funding in october 2016: net 9.4. Cash burn october 2016- januari 2017 (4 x 1.5) -6.0. So from the equity funding in october there's 3.4 left (good for staying in business[...]
$BIOC long (1/4). Will add after the placing as they're in need of funds imo.[...]
Smaihar and others, I have been long $PTN but sold out a couple of days ago. A lot of reasons for selling. Things just don't add up. To name a few and in no particular order:-Relentless selling of 0.01 warrants. They would not do that if they had expec[...]
Thank you all for responding! I have no medical background and English is not the language I use in daily life so it's quite a challenge sometimes to read medical documents written in English. I have been long $PTN but sold because of the 0.01 warrant si[...]
Anyone? Or is this such a stupid question that one finds it difficult to tell me? I already know I know nothing so no need to hold back. :)[...]
$PTN-no position.I'm breaking my head over the question if the FDA could ask for additional research regarding Brem.According to $PTN the trial included only premenopausal women. The way I'm reading the FDA Guidance ( http://www.fda.gov/download[...]
Sorry, should have read better.[...]
Long $PTN Sorry, but that's incorrect. The warrants do expire. Most, if not all, $PTN's warrants expire within 5 years .[...]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
I simply can not believe that Cytodyn $CYDY isn't mentioned here at all. They're about to file the BLA for their Leronlimab as HIV combo therapy . Last approved HIV drug had 43% respons, Leronlimab has 86% AND no SAE's no toxicity. They've had stellar resu[...]